XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1)

NCT00676520 · clinicaltrials.gov ↗

COMPLETED

Status

8053

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: XIENCE V® Everolimus Eluting Coronary Stent

Sponsor

Abbott Medical Devices